All Stories

  1. Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational

    Article • Seminars in Nuclear Medicine, November 2024, Elsevier

    Zhi Yang

  2. Targeted Positron Emission Tomography-Tracked Biomimetic Codelivery Synergistically Amplifies Ferroptosis and Pyroptosis for Inducing Lung Cancer Regression and Anti-PD-L1 Immunotherapy Efficacy

    Article • ACS Nano, October 2024, American Chemical Society (ACS)

    Zhi Yang

  3. On the shoulder of ADC: The development of 124I-IMMU-132, an iodine-124-labelled Trop-2-targeting molecular probe for micro-PET imaging

    Article • Biomedicine & Pharmacotherapy, September 2024, Elsevier

    Zhi Yang

  4. Construction and preclinical evaluation of a 124I-labelled bispecific antibody targeting PD-L1 and PD-L2

    Article • European Journal of Pediatrics, August 2024, Springer Science + Business Media

    Zhi Yang

  5. A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC

    Article • Molecular Pharmaceutics, June 2024, American Chemical Society (ACS)

    Zhi Yang

  6. Comparison of an Affibody-based Molecular Probe and 18F-FDG for Detecting HER2-Positive Breast Cancer at PET/CT

    Article • Radiology, June 2024, Radiological Society of North America (RSNA)

    Zhi Yang

  7. Preclinical imaging evaluation of a bispecific antibody targeting hPD1/CTLA4 using humanized mice

    Article • Biomedicine & Pharmacotherapy, June 2024, Elsevier

    Zhi Yang

  8. Covalent targeted radioligands potentiate radionuclide therapy

    Article • Nature, May 2024, Springer Science + Business Media

    Zhi Yang

  9. Recent Advances in Radiotracers Targeting Novel Cancer-Specific Biomarkers in China: A Brief Overview

    Article • Journal of Nuclear Medicine, May 2024, Society of Nuclear Medicine

    Zhi Yang

  10. 68Ga-NC-BCH Whole-Body PET Imaging Rapidly Targets Claudin18.2 in Lesions in Gastrointestinal Cancer Patients

    Article • Journal of Nuclear Medicine, April 2024, Society of Nuclear Medicine

    Zhi Yang

  11. Noninvasively Deciphering the Immunosuppressive Tumor Microenvironment Using Galectin-1 PET to Inform Immunotherapy Responses

    Article • Journal of Nuclear Medicine, March 2024, Society of Nuclear Medicine

    Zhi Yang

  12. KRAS Mutation Detection with (2S,4R)-4-[18F]FGln for Noninvasive PDAC Diagnosis

    Article • Molecular Pharmaceutics, March 2024, American Chemical Society (ACS)

    Zhi Yang

  13. An iodine‑labelled Antibody–drug conjugate PET probe for noninvasive monitoring of Nectin-4 expression in urothelial carcinoma

    Article • International Journal of Pharmaceutics, February 2024, Elsevier

    Zhi Yang

  14. Exploration of radionuclide labeling of a novel scFv-Fc fusion protein targeting CLDN18.2 for tumor diagnosis and treatment

    Article • European Journal of Medicinal Chemistry, February 2024, Elsevier

    Zhi Yang

  15. A bis-boron boramino acid PET tracer for brain tumor diagnosis

    Article • European Journal of Pediatrics, January 2024, Springer Science + Business Media

    Zhi Yang

  16. [177Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models

    Article • European Journal of Pediatrics, December 2023, Springer Science + Business Media

    Zhi Yang

  17. Construction and preclinical evaluation of a zirconium-89 labelled monoclonal antibody targeting PD-L2 in lung cancer

    Article • Biomedicine & Pharmacotherapy, December 2023, Elsevier

    Zhi Yang

  18. Preclinical evaluation and pilot clinical study of [68Ga]Ga-THP-APN09, a novel PD-L1 targeted nanobody radiotracer for rapid one-step radiolabeling and PET imaging

    Article • European Journal of Pediatrics, August 2023, Springer Science + Business Media

    Zhi Yang

  19. Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside

    Article • European Journal of Pediatrics, June 2023, Springer Science + Business Media

    Zhi Yang

  20. Preparation and Application of a Bioorganic Nanoparticle-Enhanced PDL1-Targeted Small-Molecule Probe

    Article • ACS Applied Materials & Interfaces, June 2023, American Chemical Society (ACS)

    Zhi Yang

  21. Diagnosis of primary lung cancer and benign pulmonary nodules: a comparison of the breath test and 18F-FDG PET-CT

    Article • Frontiers in Oncology, June 2023, Frontiers

    Zhi Yang

  22. One-Minute Iodine Isotope Labeling Technology Enables Noninvasive Tracking and Quantification of Extracellular Vesicles in Tumor Lesions and Intact Animals

    Article • Molecular Pharmaceutics, May 2023, American Chemical Society (ACS)

    Zhi Yang

  23. First-in-human CLDN18.2 functional diagnostic pet imaging of digestive system neoplasms enables whole-body target mapping and lesion detection

    Article • European Journal of Pediatrics, April 2023, Springer Science + Business Media

    Zhi Yang

  24. Comparison of renal clearance of [18F]AlF-RESCA-HER2-BCH and [18F]AlF-NOTA-HER2-BCH in mice and breast cancer patients

    Article • European Journal of Pediatrics, April 2023, Springer Science + Business Media

    Zhi Yang

  25. First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma

    Article • Clinical Cancer Research, April 2023, American Association for Cancer Research (AACR)

    Zhi Yang

  26. Development of a CLDN18.2-targeting immuno-PET probe for non-invasive imaging in gastrointestinal tumors

    Article • Journal of Pharmaceutical Analysis, April 2023, Elsevier

    Zhi Yang

  27. Preclinical Evaluation of a Fibroblast Activation Protein and a Prostate-Specific Membrane Antigen Dual-Targeted Probe for Noninvasive Prostate Cancer Imaging

    Article • Molecular Pharmaceutics, January 2023, American Chemical Society (ACS)

    Zhi Yang

  28. Diagnostic value of [68Ga]Ga-FAPI-04 in patients with colorectal cancer in comparison with [18F]F-FDG PET/CT

    Article • Frontiers in Oncology, January 2023, Frontiers

    Zhi Yang

  29. 99mTc-Rituximab sentinel lymph node mapping and biopsy, the effective technique avoids axillary dissection and predicts prognosis in 533 cutaneous melanoma

    Article • Annals of Nuclear Medicine, December 2022, Springer Science + Business Media

    Zhi Yang

  30. Construction and Preclinical Evaluation of a 124/125I-Labeled Specific Antibody Targeting PD-L2 in Lung Cancer

    Article • Molecular Pharmaceutics, December 2022, American Chemical Society (ACS)

    Zhi Yang

  31. High in-vivo stability in preclinical and first-in-human experiments with [18F]AlF-RESCA-MIRC213: a 18F-labeled nanobody as PET radiotracer for diagnosis of HER2-positive cancers

    Article • European Journal of Pediatrics, September 2022, Springer Science + Business Media

    Zhi Yang

  32. Two HER2 PET tracers: Al18F-NOTA-HER2-BCH and Al18F-RESCA-HER2-BCH were compared

    Article • Nuclear Medicine and Biology, May 2022, Elsevier

    Zhi Yang

  33. Clinical and Prognostic Value of PET/CT Imaging with Combination of 68Ga-DOTATATE and 18F-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms

    Article • Contrast Media & Molecular Imaging, January 2018, Hindawi Publishing Corporation

    Zhi Yang

  34. Better interpretation of PET/CT in DLBCL

    Article • Leukemia & Lymphoma, August 2017, Taylor & Francis

    Yuewei Zhang, Zhi Yang

  35. 68Ga/177Lu-labeled DOTA-TATE shows similar imaging and biodistribution in neuroendocrine tumor model

    Article • Tumor Biology, June 2017, SAGE Publications

    Zhi Yang